nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—ABCB1—Timolol—migraine	0.00369	0.184	CbGbCtD
Bosutinib—ABCB1—Propranolol—migraine	0.00329	0.164	CbGbCtD
Bosutinib—PTK2B—Pindolol—Propranolol—migraine	0.00289	0.524	CbGdCrCtD
Bosutinib—ABCB1—Amitriptyline—migraine	0.00285	0.142	CbGbCtD
Bosutinib—ERBB3—Alprenolol—Propranolol—migraine	0.00262	0.476	CbGdCrCtD
Bosutinib—ABCB1—Verapamil—migraine	0.00226	0.113	CbGbCtD
Bosutinib—CYP3A4—Propranolol—migraine	0.00197	0.0983	CbGbCtD
Bosutinib—CYP3A4—Amitriptyline—migraine	0.00171	0.085	CbGbCtD
Bosutinib—CYP3A4—Valproic Acid—migraine	0.00155	0.0775	CbGbCtD
Bosutinib—CYP3A4—Topiramate—migraine	0.0014	0.0699	CbGbCtD
Bosutinib—CYP3A4—Verapamil—migraine	0.00135	0.0674	CbGbCtD
Bosutinib—Bronchitis—Gabapentin—migraine	0.00087	0.00269	CcSEcCtD
Bosutinib—Infection—Verapamil—migraine	0.00087	0.00269	CcSEcCtD
Bosutinib—Urinary tract disorder—Valproic Acid—migraine	0.000863	0.00267	CcSEcCtD
Bosutinib—Oedema peripheral—Valproic Acid—migraine	0.000861	0.00266	CcSEcCtD
Bosutinib—Connective tissue disorder—Valproic Acid—migraine	0.000859	0.00265	CcSEcCtD
Bosutinib—Urethral disorder—Valproic Acid—migraine	0.000857	0.00265	CcSEcCtD
Bosutinib—Face oedema—Topiramate—migraine	0.00085	0.00263	CcSEcCtD
Bosutinib—Dyspnoea—Propranolol—migraine	0.000849	0.00262	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Gabapentin—migraine	0.000841	0.0026	CcSEcCtD
Bosutinib—Asthenia—Amitriptyline—migraine	0.000839	0.00259	CcSEcCtD
Bosutinib—Decreased appetite—Propranolol—migraine	0.000827	0.00256	CcSEcCtD
Bosutinib—Pruritus—Amitriptyline—migraine	0.000827	0.00255	CcSEcCtD
Bosutinib—Erythema multiforme—Valproic Acid—migraine	0.000826	0.00255	CcSEcCtD
Bosutinib—Blood creatinine increased—Topiramate—migraine	0.000825	0.00255	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Propranolol—migraine	0.000822	0.00254	CcSEcCtD
Bosutinib—Fatigue—Propranolol—migraine	0.000821	0.00253	CcSEcCtD
Bosutinib—Dehydration—Topiramate—migraine	0.000819	0.00253	CcSEcCtD
Bosutinib—Tinnitus—Valproic Acid—migraine	0.000815	0.00252	CcSEcCtD
Bosutinib—Pain—Propranolol—migraine	0.000814	0.00251	CcSEcCtD
Bosutinib—Pneumonia—Gabapentin—migraine	0.000812	0.00251	CcSEcCtD
Bosutinib—Agranulocytosis—Timolol—migraine	0.000809	0.0025	CcSEcCtD
Bosutinib—Infestation NOS—Gabapentin—migraine	0.000807	0.00249	CcSEcCtD
Bosutinib—Infestation—Gabapentin—migraine	0.000807	0.00249	CcSEcCtD
Bosutinib—Abdominal pain upper—Topiramate—migraine	0.000805	0.00248	CcSEcCtD
Bosutinib—Diarrhoea—Amitriptyline—migraine	0.0008	0.00247	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Verapamil—migraine	0.000798	0.00246	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Topiramate—migraine	0.000793	0.00245	CcSEcCtD
Bosutinib—Renal failure—Gabapentin—migraine	0.000793	0.00245	CcSEcCtD
Bosutinib—Immune system disorder—Valproic Acid—migraine	0.000789	0.00244	CcSEcCtD
Bosutinib—Nasopharyngitis—Topiramate—migraine	0.000788	0.00243	CcSEcCtD
Bosutinib—Mediastinal disorder—Valproic Acid—migraine	0.000787	0.00243	CcSEcCtD
Bosutinib—Dyspnoea—Verapamil—migraine	0.000781	0.00241	CcSEcCtD
Bosutinib—Gastritis—Topiramate—migraine	0.00078	0.00241	CcSEcCtD
Bosutinib—Gastrointestinal pain—Propranolol—migraine	0.000778	0.0024	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Topiramate—migraine	0.000777	0.0024	CcSEcCtD
Bosutinib—Dizziness—Amitriptyline—migraine	0.000773	0.00239	CcSEcCtD
Bosutinib—Oedema peripheral—Timolol—migraine	0.000766	0.00237	CcSEcCtD
Bosutinib—Connective tissue disorder—Timolol—migraine	0.000764	0.00236	CcSEcCtD
Bosutinib—Hepatobiliary disease—Gabapentin—migraine	0.000763	0.00236	CcSEcCtD
Bosutinib—Malnutrition—Valproic Acid—migraine	0.000761	0.00235	CcSEcCtD
Bosutinib—Urticaria—Propranolol—migraine	0.000756	0.00234	CcSEcCtD
Bosutinib—Fatigue—Verapamil—migraine	0.000755	0.00233	CcSEcCtD
Bosutinib—Abdominal pain—Propranolol—migraine	0.000752	0.00232	CcSEcCtD
Bosutinib—Body temperature increased—Propranolol—migraine	0.000752	0.00232	CcSEcCtD
Bosutinib—Pain—Verapamil—migraine	0.000749	0.00231	CcSEcCtD
Bosutinib—Dysgeusia—Valproic Acid—migraine	0.000745	0.0023	CcSEcCtD
Bosutinib—Vomiting—Amitriptyline—migraine	0.000743	0.0023	CcSEcCtD
Bosutinib—Rash—Amitriptyline—migraine	0.000737	0.00228	CcSEcCtD
Bosutinib—Dermatitis—Amitriptyline—migraine	0.000736	0.00227	CcSEcCtD
Bosutinib—Back pain—Valproic Acid—migraine	0.000736	0.00227	CcSEcCtD
Bosutinib—Headache—Amitriptyline—migraine	0.000732	0.00226	CcSEcCtD
Bosutinib—Bronchitis—Topiramate—migraine	0.000732	0.00226	CcSEcCtD
Bosutinib—Abdominal discomfort—Topiramate—migraine	0.00073	0.00225	CcSEcCtD
Bosutinib—Tinnitus—Timolol—migraine	0.000725	0.00224	CcSEcCtD
Bosutinib—Hepatitis—Gabapentin—migraine	0.000724	0.00224	CcSEcCtD
Bosutinib—Pancytopenia—Topiramate—migraine	0.000723	0.00223	CcSEcCtD
Bosutinib—Cardiac disorder—Timolol—migraine	0.000722	0.00223	CcSEcCtD
Bosutinib—Feeling abnormal—Verapamil—migraine	0.000721	0.00223	CcSEcCtD
Bosutinib—Urinary tract disorder—Gabapentin—migraine	0.000715	0.00221	CcSEcCtD
Bosutinib—Oedema peripheral—Gabapentin—migraine	0.000714	0.0022	CcSEcCtD
Bosutinib—Neutropenia—Topiramate—migraine	0.000712	0.0022	CcSEcCtD
Bosutinib—Connective tissue disorder—Gabapentin—migraine	0.000712	0.0022	CcSEcCtD
Bosutinib—Urethral disorder—Gabapentin—migraine	0.00071	0.00219	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Topiramate—migraine	0.000708	0.00219	CcSEcCtD
Bosutinib—Ill-defined disorder—Valproic Acid—migraine	0.000706	0.00218	CcSEcCtD
Bosutinib—Anaemia—Valproic Acid—migraine	0.000703	0.00217	CcSEcCtD
Bosutinib—Immune system disorder—Timolol—migraine	0.000703	0.00217	CcSEcCtD
Bosutinib—Mediastinal disorder—Timolol—migraine	0.000701	0.00217	CcSEcCtD
Bosutinib—Urticaria—Verapamil—migraine	0.000696	0.00215	CcSEcCtD
Bosutinib—Nausea—Amitriptyline—migraine	0.000694	0.00214	CcSEcCtD
Bosutinib—Malaise—Valproic Acid—migraine	0.000686	0.00212	CcSEcCtD
Bosutinib—Erythema multiforme—Gabapentin—migraine	0.000685	0.00212	CcSEcCtD
Bosutinib—Asthenia—Propranolol—migraine	0.000683	0.00211	CcSEcCtD
Bosutinib—Pneumonia—Topiramate—migraine	0.000683	0.00211	CcSEcCtD
Bosutinib—Leukopenia—Valproic Acid—migraine	0.000681	0.0021	CcSEcCtD
Bosutinib—Infestation—Topiramate—migraine	0.000679	0.0021	CcSEcCtD
Bosutinib—Infestation NOS—Topiramate—migraine	0.000679	0.0021	CcSEcCtD
Bosutinib—Malnutrition—Timolol—migraine	0.000677	0.00209	CcSEcCtD
Bosutinib—Tinnitus—Gabapentin—migraine	0.000675	0.00209	CcSEcCtD
Bosutinib—Cardiac disorder—Gabapentin—migraine	0.000672	0.00208	CcSEcCtD
Bosutinib—Renal failure—Topiramate—migraine	0.000667	0.00206	CcSEcCtD
Bosutinib—Cough—Valproic Acid—migraine	0.000664	0.00205	CcSEcCtD
Bosutinib—Dysgeusia—Timolol—migraine	0.000663	0.00205	CcSEcCtD
Bosutinib—Immune system disorder—Gabapentin—migraine	0.000654	0.00202	CcSEcCtD
Bosutinib—Mediastinal disorder—Gabapentin—migraine	0.000653	0.00202	CcSEcCtD
Bosutinib—Diarrhoea—Propranolol—migraine	0.000651	0.00201	CcSEcCtD
Bosutinib—Chest pain—Valproic Acid—migraine	0.000648	0.002	CcSEcCtD
Bosutinib—Arthralgia—Valproic Acid—migraine	0.000648	0.002	CcSEcCtD
Bosutinib—Myalgia—Valproic Acid—migraine	0.000648	0.002	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000643	0.00199	CcSEcCtD
Bosutinib—Discomfort—Valproic Acid—migraine	0.00064	0.00198	CcSEcCtD
Bosutinib—Agranulocytosis—Topiramate—migraine	0.000634	0.00196	CcSEcCtD
Bosutinib—Malnutrition—Gabapentin—migraine	0.000631	0.00195	CcSEcCtD
Bosutinib—Dizziness—Propranolol—migraine	0.000629	0.00194	CcSEcCtD
Bosutinib—Asthenia—Verapamil—migraine	0.000628	0.00194	CcSEcCtD
Bosutinib—Oedema—Valproic Acid—migraine	0.000621	0.00192	CcSEcCtD
Bosutinib—Anaphylactic shock—Valproic Acid—migraine	0.000621	0.00192	CcSEcCtD
Bosutinib—Pruritus—Verapamil—migraine	0.000619	0.00191	CcSEcCtD
Bosutinib—Dysgeusia—Gabapentin—migraine	0.000617	0.00191	CcSEcCtD
Bosutinib—Infection—Valproic Acid—migraine	0.000617	0.0019	CcSEcCtD
Bosutinib—Back pain—Gabapentin—migraine	0.00061	0.00188	CcSEcCtD
Bosutinib—Hepatitis—Topiramate—migraine	0.000609	0.00188	CcSEcCtD
Bosutinib—Nervous system disorder—Valproic Acid—migraine	0.000609	0.00188	CcSEcCtD
Bosutinib—Thrombocytopenia—Valproic Acid—migraine	0.000608	0.00188	CcSEcCtD
Bosutinib—Vomiting—Propranolol—migraine	0.000605	0.00187	CcSEcCtD
Bosutinib—Skin disorder—Valproic Acid—migraine	0.000603	0.00186	CcSEcCtD
Bosutinib—Urinary tract disorder—Topiramate—migraine	0.000602	0.00186	CcSEcCtD
Bosutinib—Oedema peripheral—Topiramate—migraine	0.0006	0.00185	CcSEcCtD
Bosutinib—Rash—Propranolol—migraine	0.0006	0.00185	CcSEcCtD
Bosutinib—Dermatitis—Propranolol—migraine	0.0006	0.00185	CcSEcCtD
Bosutinib—Diarrhoea—Verapamil—migraine	0.000599	0.00185	CcSEcCtD
Bosutinib—Connective tissue disorder—Topiramate—migraine	0.000599	0.00185	CcSEcCtD
Bosutinib—Urethral disorder—Topiramate—migraine	0.000597	0.00185	CcSEcCtD
Bosutinib—Cough—Timolol—migraine	0.000591	0.00182	CcSEcCtD
Bosutinib—Ill-defined disorder—Gabapentin—migraine	0.000585	0.00181	CcSEcCtD
Bosutinib—Anaemia—Gabapentin—migraine	0.000583	0.0018	CcSEcCtD
Bosutinib—Dizziness—Verapamil—migraine	0.000579	0.00179	CcSEcCtD
Bosutinib—Arthralgia—Timolol—migraine	0.000576	0.00178	CcSEcCtD
Bosutinib—Chest pain—Timolol—migraine	0.000576	0.00178	CcSEcCtD
Bosutinib—Myalgia—Timolol—migraine	0.000576	0.00178	CcSEcCtD
Bosutinib—Erythema multiforme—Topiramate—migraine	0.000576	0.00178	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000573	0.00177	CcSEcCtD
Bosutinib—Discomfort—Timolol—migraine	0.00057	0.00176	CcSEcCtD
Bosutinib—Malaise—Gabapentin—migraine	0.000569	0.00176	CcSEcCtD
Bosutinib—Tinnitus—Topiramate—migraine	0.000568	0.00175	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000566	0.00175	CcSEcCtD
Bosutinib—Cardiac disorder—Topiramate—migraine	0.000566	0.00175	CcSEcCtD
Bosutinib—Nausea—Propranolol—migraine	0.000565	0.00175	CcSEcCtD
Bosutinib—Leukopenia—Gabapentin—migraine	0.000564	0.00174	CcSEcCtD
Bosutinib—Vomiting—Verapamil—migraine	0.000557	0.00172	CcSEcCtD
Bosutinib—Dyspnoea—Valproic Acid—migraine	0.000553	0.00171	CcSEcCtD
Bosutinib—Oedema—Timolol—migraine	0.000553	0.00171	CcSEcCtD
Bosutinib—Anaphylactic shock—Timolol—migraine	0.000553	0.00171	CcSEcCtD
Bosutinib—Rash—Verapamil—migraine	0.000552	0.00171	CcSEcCtD
Bosutinib—Dermatitis—Verapamil—migraine	0.000552	0.0017	CcSEcCtD
Bosutinib—Immune system disorder—Topiramate—migraine	0.00055	0.0017	CcSEcCtD
Bosutinib—Cough—Gabapentin—migraine	0.00055	0.0017	CcSEcCtD
Bosutinib—Mediastinal disorder—Topiramate—migraine	0.000549	0.0017	CcSEcCtD
Bosutinib—Infection—Timolol—migraine	0.000549	0.0017	CcSEcCtD
Bosutinib—Headache—Verapamil—migraine	0.000548	0.00169	CcSEcCtD
Bosutinib—STK3—cerebellum—migraine	0.000544	0.00162	CbGeAlD
Bosutinib—ERBB4—cerebellum—migraine	0.000544	0.00162	CbGeAlD
Bosutinib—MERTK—nervous system—migraine	0.000544	0.00162	CbGeAlD
Bosutinib—MAP2K1—head—migraine	0.000544	0.00162	CbGeAlD
Bosutinib—STK35—head—migraine	0.000544	0.00162	CbGeAlD
Bosutinib—Nervous system disorder—Timolol—migraine	0.000542	0.00167	CcSEcCtD
Bosutinib—CSK—head—migraine	0.00054	0.00161	CbGeAlD
Bosutinib—Decreased appetite—Valproic Acid—migraine	0.00054	0.00167	CcSEcCtD
Bosutinib—STK25—brain—migraine	0.000538	0.0016	CbGeAlD
Bosutinib—Chest pain—Gabapentin—migraine	0.000537	0.00166	CcSEcCtD
Bosutinib—Arthralgia—Gabapentin—migraine	0.000537	0.00166	CcSEcCtD
Bosutinib—Myalgia—Gabapentin—migraine	0.000537	0.00166	CcSEcCtD
Bosutinib—Skin disorder—Timolol—migraine	0.000537	0.00166	CcSEcCtD
Bosutinib—CSNK1A1—head—migraine	0.000536	0.0016	CbGeAlD
Bosutinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000536	0.00166	CcSEcCtD
Bosutinib—Fatigue—Valproic Acid—migraine	0.000535	0.00165	CcSEcCtD
Bosutinib—EPHA3—brain—migraine	0.000534	0.00159	CbGeAlD
Bosutinib—BMPR2—central nervous system—migraine	0.000534	0.00159	CbGeAlD
Bosutinib—MAP4K4—nervous system—migraine	0.000534	0.00159	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000533	0.00165	CcSEcCtD
Bosutinib—CLK1—head—migraine	0.000533	0.00159	CbGeAlD
Bosutinib—HCK—head—migraine	0.000533	0.00159	CbGeAlD
Bosutinib—SRC—cardiovascular system—migraine	0.000532	0.00158	CbGeAlD
Bosutinib—Pain—Valproic Acid—migraine	0.000531	0.00164	CcSEcCtD
Bosutinib—Malnutrition—Topiramate—migraine	0.000531	0.00164	CcSEcCtD
Bosutinib—Discomfort—Gabapentin—migraine	0.00053	0.00164	CcSEcCtD
Bosutinib—BCR—nervous system—migraine	0.00053	0.00158	CbGeAlD
Bosutinib—STK36—central nervous system—migraine	0.000529	0.00158	CbGeAlD
Bosutinib—EPHB3—central nervous system—migraine	0.000529	0.00158	CbGeAlD
Bosutinib—MAP3K12—nervous system—migraine	0.000526	0.00157	CbGeAlD
Bosutinib—MERTK—central nervous system—migraine	0.000523	0.00156	CbGeAlD
Bosutinib—PLK2—brain—migraine	0.000523	0.00156	CbGeAlD
Bosutinib—BMP2K—head—migraine	0.000523	0.00156	CbGeAlD
Bosutinib—CAMK2G—head—migraine	0.000523	0.00156	CbGeAlD
Bosutinib—ABL1—trigeminal ganglion—migraine	0.000522	0.00156	CbGeAlD
Bosutinib—BMPR2—cerebellum—migraine	0.000522	0.00155	CbGeAlD
Bosutinib—Nausea—Verapamil—migraine	0.00052	0.00161	CcSEcCtD
Bosutinib—SIK3—brain—migraine	0.00052	0.00155	CbGeAlD
Bosutinib—Dysgeusia—Topiramate—migraine	0.00052	0.0016	CcSEcCtD
Bosutinib—LRRK2—head—migraine	0.000518	0.00154	CbGeAlD
Bosutinib—EPHB3—cerebellum—migraine	0.000517	0.00154	CbGeAlD
Bosutinib—STK36—cerebellum—migraine	0.000517	0.00154	CbGeAlD
Bosutinib—MAP2K1—nervous system—migraine	0.000515	0.00153	CbGeAlD
Bosutinib—STK35—nervous system—migraine	0.000515	0.00153	CbGeAlD
Bosutinib—Oedema—Gabapentin—migraine	0.000515	0.00159	CcSEcCtD
Bosutinib—Anaphylactic shock—Gabapentin—migraine	0.000515	0.00159	CcSEcCtD
Bosutinib—MAP4K4—central nervous system—migraine	0.000514	0.00153	CbGeAlD
Bosutinib—Back pain—Topiramate—migraine	0.000513	0.00158	CcSEcCtD
Bosutinib—CSK—nervous system—migraine	0.000512	0.00152	CbGeAlD
Bosutinib—Feeling abnormal—Valproic Acid—migraine	0.000512	0.00158	CcSEcCtD
Bosutinib—MERTK—cerebellum—migraine	0.000512	0.00152	CbGeAlD
Bosutinib—Infection—Gabapentin—migraine	0.000511	0.00158	CcSEcCtD
Bosutinib—BCR—central nervous system—migraine	0.00051	0.00152	CbGeAlD
Bosutinib—CSNK1A1—nervous system—migraine	0.000509	0.00151	CbGeAlD
Bosutinib—Gastrointestinal pain—Valproic Acid—migraine	0.000508	0.00157	CcSEcCtD
Bosutinib—MAP3K12—central nervous system—migraine	0.000506	0.00151	CbGeAlD
Bosutinib—HCK—nervous system—migraine	0.000505	0.0015	CbGeAlD
Bosutinib—CLK1—nervous system—migraine	0.000505	0.0015	CbGeAlD
Bosutinib—PTK2B—head—migraine	0.000505	0.0015	CbGeAlD
Bosutinib—Nervous system disorder—Gabapentin—migraine	0.000505	0.00156	CcSEcCtD
Bosutinib—Thrombocytopenia—Gabapentin—migraine	0.000504	0.00156	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Timolol—migraine	0.000503	0.00156	CcSEcCtD
Bosutinib—MAP4K4—cerebellum—migraine	0.000502	0.0015	CbGeAlD
Bosutinib—STK4—brain—migraine	0.0005	0.00149	CbGeAlD
Bosutinib—Skin disorder—Gabapentin—migraine	0.0005	0.00154	CcSEcCtD
Bosutinib—BCR—cerebellum—migraine	0.000498	0.00148	CbGeAlD
Bosutinib—NUAK2—cerebellum—migraine	0.000498	0.00148	CbGeAlD
Bosutinib—CSNK1E—head—migraine	0.000497	0.00148	CbGeAlD
Bosutinib—MAP2K1—central nervous system—migraine	0.000496	0.00148	CbGeAlD
Bosutinib—STK35—central nervous system—migraine	0.000496	0.00148	CbGeAlD
Bosutinib—BMP2K—nervous system—migraine	0.000496	0.00148	CbGeAlD
Bosutinib—CAMK2G—nervous system—migraine	0.000496	0.00148	CbGeAlD
Bosutinib—MAP3K12—cerebellum—migraine	0.000495	0.00147	CbGeAlD
Bosutinib—CAMK1D—brain—migraine	0.000494	0.00147	CbGeAlD
Bosutinib—Urticaria—Valproic Acid—migraine	0.000493	0.00152	CcSEcCtD
Bosutinib—CSK—central nervous system—migraine	0.000493	0.00147	CbGeAlD
Bosutinib—Dyspnoea—Timolol—migraine	0.000493	0.00152	CcSEcCtD
Bosutinib—Ill-defined disorder—Topiramate—migraine	0.000492	0.00152	CcSEcCtD
Bosutinib—LRRK2—nervous system—migraine	0.000492	0.00146	CbGeAlD
Bosutinib—Body temperature increased—Valproic Acid—migraine	0.000491	0.00152	CcSEcCtD
Bosutinib—Abdominal pain—Valproic Acid—migraine	0.000491	0.00152	CcSEcCtD
Bosutinib—Anaemia—Topiramate—migraine	0.00049	0.00151	CcSEcCtD
Bosutinib—CSNK1A1—central nervous system—migraine	0.00049	0.00146	CbGeAlD
Bosutinib—SIK1—head—migraine	0.000489	0.00146	CbGeAlD
Bosutinib—IRAK4—head—migraine	0.000489	0.00146	CbGeAlD
Bosutinib—MAP2K5—cardiovascular system—migraine	0.000489	0.00146	CbGeAlD
Bosutinib—STK24—brain—migraine	0.000489	0.00146	CbGeAlD
Bosutinib—CLK1—central nervous system—migraine	0.000487	0.00145	CbGeAlD
Bosutinib—HCK—central nervous system—migraine	0.000487	0.00145	CbGeAlD
Bosutinib—STK35—cerebellum—migraine	0.000485	0.00144	CbGeAlD
Bosutinib—MAP2K1—cerebellum—migraine	0.000485	0.00144	CbGeAlD
Bosutinib—EPHA4—head—migraine	0.000484	0.00144	CbGeAlD
Bosutinib—CSK—cerebellum—migraine	0.000482	0.00143	CbGeAlD
Bosutinib—Decreased appetite—Timolol—migraine	0.00048	0.00148	CcSEcCtD
Bosutinib—ERBB3—head—migraine	0.00048	0.00143	CbGeAlD
Bosutinib—PTK2B—nervous system—migraine	0.000479	0.00143	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—migraine	0.000479	0.00143	CbGeAlD
Bosutinib—MAP2K2—head—migraine	0.000479	0.00143	CbGeAlD
Bosutinib—ULK3—head—migraine	0.000479	0.00143	CbGeAlD
Bosutinib—Malaise—Topiramate—migraine	0.000478	0.00148	CcSEcCtD
Bosutinib—CAMK2G—central nervous system—migraine	0.000478	0.00142	CbGeAlD
Bosutinib—BMP2K—central nervous system—migraine	0.000478	0.00142	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—migraine	0.000477	0.00142	CbGeAlD
Bosutinib—Gastrointestinal disorder—Timolol—migraine	0.000477	0.00147	CcSEcCtD
Bosutinib—Fatigue—Timolol—migraine	0.000476	0.00147	CcSEcCtD
Bosutinib—CLK1—cerebellum—migraine	0.000476	0.00142	CbGeAlD
Bosutinib—MAP3K2—head—migraine	0.000475	0.00141	CbGeAlD
Bosutinib—Leukopenia—Topiramate—migraine	0.000475	0.00147	CcSEcCtD
Bosutinib—LRRK2—central nervous system—migraine	0.000473	0.00141	CbGeAlD
Bosutinib—ALK—brain—migraine	0.000473	0.00141	CbGeAlD
Bosutinib—EPHA5—brain—migraine	0.000473	0.00141	CbGeAlD
Bosutinib—TYRO3—brain—migraine	0.000473	0.00141	CbGeAlD
Bosutinib—FER—brain—migraine	0.000473	0.00141	CbGeAlD
Bosutinib—Pain—Timolol—migraine	0.000473	0.00146	CcSEcCtD
Bosutinib—ABL2—cerebellum—migraine	0.000473	0.00141	CbGeAlD
Bosutinib—CSNK1E—nervous system—migraine	0.000471	0.0014	CbGeAlD
Bosutinib—LYN—brain—migraine	0.00047	0.0014	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Gabapentin—migraine	0.000469	0.00145	CcSEcCtD
Bosutinib—BMP2K—cerebellum—migraine	0.000467	0.00139	CbGeAlD
Bosutinib—CAMK2G—cerebellum—migraine	0.000467	0.00139	CbGeAlD
Bosutinib—TBK1—head—migraine	0.000465	0.00139	CbGeAlD
Bosutinib—PTK2—head—migraine	0.000465	0.00139	CbGeAlD
Bosutinib—SIK1—nervous system—migraine	0.000464	0.00138	CbGeAlD
Bosutinib—IRAK4—nervous system—migraine	0.000464	0.00138	CbGeAlD
Bosutinib—MAP4K1—brain—migraine	0.000463	0.00138	CbGeAlD
Bosutinib—MAP3K19—brain—migraine	0.000463	0.00138	CbGeAlD
Bosutinib—Cough—Topiramate—migraine	0.000463	0.00143	CcSEcCtD
Bosutinib—LRRK2—cerebellum—migraine	0.000463	0.00138	CbGeAlD
Bosutinib—ABL1—brainstem—migraine	0.000462	0.00138	CbGeAlD
Bosutinib—EGFR—cerebellum—migraine	0.000461	0.00137	CbGeAlD
Bosutinib—PTK2B—central nervous system—migraine	0.000461	0.00137	CbGeAlD
Bosutinib—BTK—brain—migraine	0.000461	0.00137	CbGeAlD
Bosutinib—EPHA4—nervous system—migraine	0.000459	0.00137	CbGeAlD
Bosutinib—Dyspnoea—Gabapentin—migraine	0.000459	0.00142	CcSEcCtD
Bosutinib—Feeling abnormal—Timolol—migraine	0.000455	0.00141	CcSEcCtD
Bosutinib—ERBB3—nervous system—migraine	0.000455	0.00135	CbGeAlD
Bosutinib—TNK2—brain—migraine	0.000454	0.00135	CbGeAlD
Bosutinib—CSNK1E—central nervous system—migraine	0.000454	0.00135	CbGeAlD
Bosutinib—ULK3—nervous system—migraine	0.000454	0.00135	CbGeAlD
Bosutinib—MAP2K2—nervous system—migraine	0.000454	0.00135	CbGeAlD
Bosutinib—Gastrointestinal pain—Timolol—migraine	0.000452	0.0014	CcSEcCtD
Bosutinib—Chest pain—Topiramate—migraine	0.000452	0.00139	CcSEcCtD
Bosutinib—Myalgia—Topiramate—migraine	0.000452	0.00139	CcSEcCtD
Bosutinib—Arthralgia—Topiramate—migraine	0.000452	0.00139	CcSEcCtD
Bosutinib—PTK2B—cerebellum—migraine	0.000451	0.00134	CbGeAlD
Bosutinib—MAP3K2—nervous system—migraine	0.00045	0.00134	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000449	0.00139	CcSEcCtD
Bosutinib—MAP4K2—brain—migraine	0.000448	0.00133	CbGeAlD
Bosutinib—RPS6KB1—head—migraine	0.000448	0.00133	CbGeAlD
Bosutinib—Decreased appetite—Gabapentin—migraine	0.000447	0.00138	CcSEcCtD
Bosutinib—SIK1—central nervous system—migraine	0.000447	0.00133	CbGeAlD
Bosutinib—IRAK4—central nervous system—migraine	0.000447	0.00133	CbGeAlD
Bosutinib—Discomfort—Topiramate—migraine	0.000446	0.00138	CcSEcCtD
Bosutinib—Asthenia—Valproic Acid—migraine	0.000445	0.00138	CcSEcCtD
Bosutinib—FGR—head—migraine	0.000445	0.00132	CbGeAlD
Bosutinib—Gastrointestinal disorder—Gabapentin—migraine	0.000444	0.00137	CcSEcCtD
Bosutinib—Fatigue—Gabapentin—migraine	0.000444	0.00137	CcSEcCtD
Bosutinib—CSNK1E—cerebellum—migraine	0.000443	0.00132	CbGeAlD
Bosutinib—AXL—head—migraine	0.000443	0.00132	CbGeAlD
Bosutinib—EPHA4—central nervous system—migraine	0.000442	0.00132	CbGeAlD
Bosutinib—ERBB4—brain—migraine	0.000442	0.00132	CbGeAlD
Bosutinib—STK3—brain—migraine	0.000442	0.00132	CbGeAlD
Bosutinib—PTK2—nervous system—migraine	0.000441	0.00131	CbGeAlD
Bosutinib—TBK1—nervous system—migraine	0.000441	0.00131	CbGeAlD
Bosutinib—Pain—Gabapentin—migraine	0.00044	0.00136	CcSEcCtD
Bosutinib—Pruritus—Valproic Acid—migraine	0.000439	0.00136	CcSEcCtD
Bosutinib—Urticaria—Timolol—migraine	0.000439	0.00136	CcSEcCtD
Bosutinib—ERBB3—central nervous system—migraine	0.000438	0.0013	CbGeAlD
Bosutinib—Body temperature increased—Timolol—migraine	0.000437	0.00135	CcSEcCtD
Bosutinib—Abdominal pain—Timolol—migraine	0.000437	0.00135	CcSEcCtD
Bosutinib—ULK3—central nervous system—migraine	0.000437	0.0013	CbGeAlD
Bosutinib—MAP2K2—central nervous system—migraine	0.000437	0.0013	CbGeAlD
Bosutinib—IRAK4—cerebellum—migraine	0.000437	0.0013	CbGeAlD
Bosutinib—SIK1—cerebellum—migraine	0.000437	0.0013	CbGeAlD
Bosutinib—ROCK1—brain—migraine	0.000436	0.0013	CbGeAlD
Bosutinib—MAP3K2—central nervous system—migraine	0.000434	0.00129	CbGeAlD
Bosutinib—Oedema—Topiramate—migraine	0.000433	0.00134	CcSEcCtD
Bosutinib—EPHA4—cerebellum—migraine	0.000432	0.00129	CbGeAlD
Bosutinib—Infection—Topiramate—migraine	0.00043	0.00133	CcSEcCtD
Bosutinib—ERBB3—cerebellum—migraine	0.000428	0.00127	CbGeAlD
Bosutinib—ULK3—cerebellum—migraine	0.000427	0.00127	CbGeAlD
Bosutinib—MAP2K2—cerebellum—migraine	0.000427	0.00127	CbGeAlD
Bosutinib—Diarrhoea—Valproic Acid—migraine	0.000425	0.00131	CcSEcCtD
Bosutinib—TBK1—central nervous system—migraine	0.000425	0.00126	CbGeAlD
Bosutinib—PTK2—central nervous system—migraine	0.000425	0.00126	CbGeAlD
Bosutinib—Nervous system disorder—Topiramate—migraine	0.000425	0.00131	CcSEcCtD
Bosutinib—RPS6KB1—nervous system—migraine	0.000424	0.00126	CbGeAlD
Bosutinib—Feeling abnormal—Gabapentin—migraine	0.000424	0.00131	CcSEcCtD
Bosutinib—Thrombocytopenia—Topiramate—migraine	0.000424	0.00131	CcSEcCtD
Bosutinib—MAP3K2—cerebellum—migraine	0.000424	0.00126	CbGeAlD
Bosutinib—BMPR2—brain—migraine	0.000424	0.00126	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—migraine	0.000423	0.00126	CbGeAlD
Bosutinib—FGR—nervous system—migraine	0.000422	0.00126	CbGeAlD
Bosutinib—Gastrointestinal pain—Gabapentin—migraine	0.000421	0.0013	CcSEcCtD
Bosutinib—Skin disorder—Topiramate—migraine	0.000421	0.0013	CcSEcCtD
Bosutinib—STK36—brain—migraine	0.00042	0.00125	CbGeAlD
Bosutinib—EPHB3—brain—migraine	0.00042	0.00125	CbGeAlD
Bosutinib—AXL—nervous system—migraine	0.00042	0.00125	CbGeAlD
Bosutinib—MAP3K7—cerebellum—migraine	0.00042	0.00125	CbGeAlD
Bosutinib—MERTK—brain—migraine	0.000415	0.00124	CbGeAlD
Bosutinib—EPHA2—head—migraine	0.000415	0.00124	CbGeAlD
Bosutinib—PTK2—cerebellum—migraine	0.000415	0.00124	CbGeAlD
Bosutinib—TBK1—cerebellum—migraine	0.000415	0.00124	CbGeAlD
Bosutinib—FYN—head—migraine	0.000415	0.00123	CbGeAlD
Bosutinib—Dizziness—Valproic Acid—migraine	0.000411	0.00127	CcSEcCtD
Bosutinib—Urticaria—Gabapentin—migraine	0.000409	0.00126	CcSEcCtD
Bosutinib—RPS6KB1—central nervous system—migraine	0.000409	0.00122	CbGeAlD
Bosutinib—MAP4K4—brain—migraine	0.000408	0.00121	CbGeAlD
Bosutinib—IRAK1—cerebellum—migraine	0.000407	0.00121	CbGeAlD
Bosutinib—Body temperature increased—Gabapentin—migraine	0.000407	0.00126	CcSEcCtD
Bosutinib—Abdominal pain—Gabapentin—migraine	0.000407	0.00126	CcSEcCtD
Bosutinib—FGR—central nervous system—migraine	0.000406	0.00121	CbGeAlD
Bosutinib—MAP3K3—head—migraine	0.000405	0.00121	CbGeAlD
Bosutinib—MAP4K5—head—migraine	0.000405	0.00121	CbGeAlD
Bosutinib—BCR—brain—migraine	0.000405	0.00121	CbGeAlD
Bosutinib—NUAK2—brain—migraine	0.000405	0.00121	CbGeAlD
Bosutinib—AXL—central nervous system—migraine	0.000404	0.0012	CbGeAlD
Bosutinib—MAP3K12—brain—migraine	0.000402	0.0012	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—migraine	0.000399	0.00119	CbGeAlD
Bosutinib—Asthenia—Timolol—migraine	0.000396	0.00122	CcSEcCtD
Bosutinib—AXL—cerebellum—migraine	0.000395	0.00118	CbGeAlD
Bosutinib—Vomiting—Valproic Acid—migraine	0.000395	0.00122	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Topiramate—migraine	0.000394	0.00122	CcSEcCtD
Bosutinib—MAP2K1—brain—migraine	0.000394	0.00117	CbGeAlD
Bosutinib—STK35—brain—migraine	0.000394	0.00117	CbGeAlD
Bosutinib—EPHA2—nervous system—migraine	0.000394	0.00117	CbGeAlD
Bosutinib—FYN—nervous system—migraine	0.000393	0.00117	CbGeAlD
Bosutinib—Rash—Valproic Acid—migraine	0.000391	0.00121	CcSEcCtD
Bosutinib—CSK—brain—migraine	0.000391	0.00117	CbGeAlD
Bosutinib—Dermatitis—Valproic Acid—migraine	0.000391	0.00121	CcSEcCtD
Bosutinib—Pruritus—Timolol—migraine	0.000391	0.00121	CcSEcCtD
Bosutinib—Headache—Valproic Acid—migraine	0.000389	0.0012	CcSEcCtD
Bosutinib—CSNK1A1—brain—migraine	0.000389	0.00116	CbGeAlD
Bosutinib—HCK—brain—migraine	0.000386	0.00115	CbGeAlD
Bosutinib—CLK1—brain—migraine	0.000386	0.00115	CbGeAlD
Bosutinib—Dyspnoea—Topiramate—migraine	0.000386	0.00119	CcSEcCtD
Bosutinib—MAP4K5—nervous system—migraine	0.000384	0.00114	CbGeAlD
Bosutinib—MAP3K3—nervous system—migraine	0.000384	0.00114	CbGeAlD
Bosutinib—ABL2—brain—migraine	0.000384	0.00114	CbGeAlD
Bosutinib—SLK—cerebellum—migraine	0.000381	0.00113	CbGeAlD
Bosutinib—EPHA2—central nervous system—migraine	0.000379	0.00113	CbGeAlD
Bosutinib—CAMK2G—brain—migraine	0.000379	0.00113	CbGeAlD
Bosutinib—BMP2K—brain—migraine	0.000379	0.00113	CbGeAlD
Bosutinib—FYN—central nervous system—migraine	0.000379	0.00113	CbGeAlD
Bosutinib—Diarrhoea—Timolol—migraine	0.000378	0.00117	CcSEcCtD
Bosutinib—EPHB4—cerebellum—migraine	0.000378	0.00113	CbGeAlD
Bosutinib—ABL1—cardiovascular system—migraine	0.000377	0.00112	CbGeAlD
Bosutinib—Decreased appetite—Topiramate—migraine	0.000376	0.00116	CcSEcCtD
Bosutinib—LRRK2—brain—migraine	0.000376	0.00112	CbGeAlD
Bosutinib—EGFR—brain—migraine	0.000375	0.00112	CbGeAlD
Bosutinib—YES1—head—migraine	0.000374	0.00111	CbGeAlD
Bosutinib—Gastrointestinal disorder—Topiramate—migraine	0.000374	0.00115	CcSEcCtD
Bosutinib—Fatigue—Topiramate—migraine	0.000373	0.00115	CcSEcCtD
Bosutinib—STK10—head—migraine	0.000371	0.0011	CbGeAlD
Bosutinib—Pain—Topiramate—migraine	0.00037	0.00114	CcSEcCtD
Bosutinib—FYN—cerebellum—migraine	0.00037	0.0011	CbGeAlD
Bosutinib—MAP3K3—central nervous system—migraine	0.00037	0.0011	CbGeAlD
Bosutinib—MAP4K5—central nervous system—migraine	0.00037	0.0011	CbGeAlD
Bosutinib—TAOK3—head—migraine	0.000369	0.0011	CbGeAlD
Bosutinib—Asthenia—Gabapentin—migraine	0.000369	0.00114	CcSEcCtD
Bosutinib—Nausea—Valproic Acid—migraine	0.000369	0.00114	CcSEcCtD
Bosutinib—PTK2B—brain—migraine	0.000366	0.00109	CbGeAlD
Bosutinib—Dizziness—Timolol—migraine	0.000365	0.00113	CcSEcCtD
Bosutinib—Pruritus—Gabapentin—migraine	0.000364	0.00112	CcSEcCtD
Bosutinib—MAP3K3—cerebellum—migraine	0.000362	0.00108	CbGeAlD
Bosutinib—MAP4K5—cerebellum—migraine	0.000362	0.00108	CbGeAlD
Bosutinib—CSNK1E—brain—migraine	0.00036	0.00107	CbGeAlD
Bosutinib—SRC—head—migraine	0.00036	0.00107	CbGeAlD
Bosutinib—Feeling abnormal—Topiramate—migraine	0.000357	0.0011	CcSEcCtD
Bosutinib—YES1—nervous system—migraine	0.000355	0.00106	CbGeAlD
Bosutinib—SIK1—brain—migraine	0.000355	0.00106	CbGeAlD
Bosutinib—IRAK4—brain—migraine	0.000355	0.00106	CbGeAlD
Bosutinib—Gastrointestinal pain—Topiramate—migraine	0.000354	0.00109	CcSEcCtD
Bosutinib—Diarrhoea—Gabapentin—migraine	0.000352	0.00109	CcSEcCtD
Bosutinib—STK10—nervous system—migraine	0.000352	0.00105	CbGeAlD
Bosutinib—Vomiting—Timolol—migraine	0.000351	0.00109	CcSEcCtD
Bosutinib—EPHA4—brain—migraine	0.000351	0.00105	CbGeAlD
Bosutinib—TAOK3—nervous system—migraine	0.00035	0.00104	CbGeAlD
Bosutinib—Rash—Timolol—migraine	0.000348	0.00108	CcSEcCtD
Bosutinib—Dermatitis—Timolol—migraine	0.000348	0.00108	CcSEcCtD
Bosutinib—ERBB3—brain—migraine	0.000348	0.00104	CbGeAlD
Bosutinib—MAP2K2—brain—migraine	0.000347	0.00103	CbGeAlD
Bosutinib—ULK3—brain—migraine	0.000347	0.00103	CbGeAlD
Bosutinib—Headache—Timolol—migraine	0.000346	0.00107	CcSEcCtD
Bosutinib—MAP3K2—brain—migraine	0.000344	0.00103	CbGeAlD
Bosutinib—Urticaria—Topiramate—migraine	0.000344	0.00106	CcSEcCtD
Bosutinib—Body temperature increased—Topiramate—migraine	0.000342	0.00106	CcSEcCtD
Bosutinib—Abdominal pain—Topiramate—migraine	0.000342	0.00106	CcSEcCtD
Bosutinib—YES1—central nervous system—migraine	0.000342	0.00102	CbGeAlD
Bosutinib—SRC—nervous system—migraine	0.000341	0.00102	CbGeAlD
Bosutinib—MAP3K7—brain—migraine	0.000341	0.00102	CbGeAlD
Bosutinib—Dizziness—Gabapentin—migraine	0.00034	0.00105	CcSEcCtD
Bosutinib—STK10—central nervous system—migraine	0.000339	0.00101	CbGeAlD
Bosutinib—TAOK3—central nervous system—migraine	0.000337	0.001	CbGeAlD
Bosutinib—PTK2—brain—migraine	0.000337	0.001	CbGeAlD
Bosutinib—TBK1—brain—migraine	0.000337	0.001	CbGeAlD
Bosutinib—YES1—cerebellum—migraine	0.000334	0.000994	CbGeAlD
Bosutinib—MAP2K5—head—migraine	0.000331	0.000986	CbGeAlD
Bosutinib—STK10—cerebellum—migraine	0.000331	0.000985	CbGeAlD
Bosutinib—IRAK1—brain—migraine	0.000331	0.000984	CbGeAlD
Bosutinib—TAOK3—cerebellum—migraine	0.00033	0.000982	CbGeAlD
Bosutinib—SRC—central nervous system—migraine	0.000329	0.000979	CbGeAlD
Bosutinib—Nausea—Timolol—migraine	0.000328	0.00101	CcSEcCtD
Bosutinib—Vomiting—Gabapentin—migraine	0.000327	0.00101	CcSEcCtD
Bosutinib—Rash—Gabapentin—migraine	0.000324	0.001	CcSEcCtD
Bosutinib—RPS6KB1—brain—migraine	0.000324	0.000966	CbGeAlD
Bosutinib—Dermatitis—Gabapentin—migraine	0.000324	0.001	CcSEcCtD
Bosutinib—CSF1R—head—migraine	0.000323	0.000963	CbGeAlD
Bosutinib—Headache—Gabapentin—migraine	0.000322	0.000996	CcSEcCtD
Bosutinib—FGR—brain—migraine	0.000322	0.00096	CbGeAlD
Bosutinib—SRC—cerebellum—migraine	0.000321	0.000957	CbGeAlD
Bosutinib—AXL—brain—migraine	0.000321	0.000956	CbGeAlD
Bosutinib—MAP2K5—nervous system—migraine	0.000314	0.000935	CbGeAlD
Bosutinib—Asthenia—Topiramate—migraine	0.000311	0.000959	CcSEcCtD
Bosutinib—SLK—brain—migraine	0.000309	0.00092	CbGeAlD
Bosutinib—EPHB4—brain—migraine	0.000307	0.000914	CbGeAlD
Bosutinib—CSF1R—nervous system—migraine	0.000306	0.000913	CbGeAlD
Bosutinib—Pruritus—Topiramate—migraine	0.000306	0.000946	CcSEcCtD
Bosutinib—Nausea—Gabapentin—migraine	0.000306	0.000944	CcSEcCtD
Bosutinib—MAP2K5—central nervous system—migraine	0.000302	0.0009	CbGeAlD
Bosutinib—EPHA2—brain—migraine	0.000301	0.000896	CbGeAlD
Bosutinib—FYN—brain—migraine	0.000301	0.000895	CbGeAlD
Bosutinib—Diarrhoea—Topiramate—migraine	0.000296	0.000915	CcSEcCtD
Bosutinib—MAP2K5—cerebellum—migraine	0.000295	0.00088	CbGeAlD
Bosutinib—CSF1R—central nervous system—migraine	0.000295	0.000879	CbGeAlD
Bosutinib—MAP4K5—brain—migraine	0.000294	0.000875	CbGeAlD
Bosutinib—MAP3K3—brain—migraine	0.000294	0.000875	CbGeAlD
Bosutinib—CSF1R—cerebellum—migraine	0.000288	0.000859	CbGeAlD
Bosutinib—PDGFRB—head—migraine	0.000287	0.000854	CbGeAlD
Bosutinib—Dizziness—Topiramate—migraine	0.000286	0.000884	CcSEcCtD
Bosutinib—Vomiting—Topiramate—migraine	0.000275	0.00085	CcSEcCtD
Bosutinib—Rash—Topiramate—migraine	0.000273	0.000843	CcSEcCtD
Bosutinib—Dermatitis—Topiramate—migraine	0.000273	0.000842	CcSEcCtD
Bosutinib—PDGFRB—nervous system—migraine	0.000272	0.000809	CbGeAlD
Bosutinib—Headache—Topiramate—migraine	0.000271	0.000838	CcSEcCtD
Bosutinib—YES1—brain—migraine	0.000271	0.000808	CbGeAlD
Bosutinib—STK10—brain—migraine	0.000269	0.0008	CbGeAlD
Bosutinib—TAOK3—brain—migraine	0.000268	0.000797	CbGeAlD
Bosutinib—ABCB1—blood vessel—migraine	0.000263	0.000783	CbGeAlD
Bosutinib—PDGFRB—central nervous system—migraine	0.000262	0.000779	CbGeAlD
Bosutinib—SRC—brain—migraine	0.000261	0.000777	CbGeAlD
Bosutinib—Nausea—Topiramate—migraine	0.000257	0.000794	CcSEcCtD
Bosutinib—PDGFRB—cerebellum—migraine	0.000256	0.000762	CbGeAlD
Bosutinib—ABL1—head—migraine	0.000256	0.000761	CbGeAlD
Bosutinib—ABL1—nervous system—migraine	0.000242	0.000721	CbGeAlD
Bosutinib—MAP2K5—brain—migraine	0.00024	0.000715	CbGeAlD
Bosutinib—CSF1R—brain—migraine	0.000234	0.000698	CbGeAlD
Bosutinib—ABL1—central nervous system—migraine	0.000233	0.000695	CbGeAlD
Bosutinib—ABL1—cerebellum—migraine	0.000228	0.000679	CbGeAlD
Bosutinib—PDGFRB—brain—migraine	0.000208	0.000619	CbGeAlD
Bosutinib—ABL1—brain—migraine	0.000185	0.000551	CbGeAlD
Bosutinib—ABCB1—trigeminal ganglion—migraine	0.000162	0.000484	CbGeAlD
Bosutinib—ABCB1—cardiovascular system—migraine	0.000117	0.000349	CbGeAlD
Bosutinib—CYP3A4—nervous system—migraine	0.000106	0.000317	CbGeAlD
Bosutinib—CYP3A4—central nervous system—migraine	0.000102	0.000305	CbGeAlD
Bosutinib—ABCB1—head—migraine	7.95e-05	0.000237	CbGeAlD
Bosutinib—ABCB1—nervous system—migraine	7.53e-05	0.000224	CbGeAlD
Bosutinib—ABCB1—central nervous system—migraine	7.25e-05	0.000216	CbGeAlD
Bosutinib—ABCB1—cerebellum—migraine	7.09e-05	0.000211	CbGeAlD
Bosutinib—ABCB1—brain—migraine	5.76e-05	0.000171	CbGeAlD
Bosutinib—LCK—Signaling Pathways—HTR2B—migraine	3.1e-05	9.86e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—ESR1—migraine	3.1e-05	9.85e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—ESR1—migraine	3.1e-05	9.85e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CALCA—migraine	3.09e-05	9.82e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HTR2C—migraine	3.08e-05	9.77e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HTR7—migraine	3.07e-05	9.75e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—MTHFR—migraine	3.07e-05	9.74e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NOTCH4—migraine	3.06e-05	9.73e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—FOS—migraine	3.05e-05	9.7e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EDNRA—migraine	3.03e-05	9.64e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR1A—migraine	3.02e-05	9.6e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CALCA—migraine	3.02e-05	9.59e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—FOS—migraine	3.02e-05	9.58e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CALCA—migraine	3e-05	9.54e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFBR2—migraine	3e-05	9.52e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—ESR1—migraine	2.99e-05	9.51e-05	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—TNF—migraine	2.99e-05	9.51e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EDNRA—migraine	2.99e-05	9.51e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—FOS—migraine	2.99e-05	9.49e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NPS—migraine	2.98e-05	9.45e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PGR—migraine	2.98e-05	9.45e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TAC1—migraine	2.98e-05	9.45e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—FOS—migraine	2.98e-05	9.45e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—FOS—migraine	2.97e-05	9.45e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NOTCH3—migraine	2.96e-05	9.39e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFBR2—migraine	2.96e-05	9.39e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR1B—migraine	2.96e-05	9.39e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR1D—migraine	2.96e-05	9.39e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—FOS—migraine	2.94e-05	9.35e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—FOS—migraine	2.93e-05	9.3e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CALCA—migraine	2.92e-05	9.28e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR2C—migraine	2.92e-05	9.27e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NOTCH3—migraine	2.92e-05	9.26e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—FOS—migraine	2.9e-05	9.22e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HTR7—migraine	2.89e-05	9.19e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—FOS—migraine	2.89e-05	9.19e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CALCA—migraine	2.88e-05	9.15e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFBR2—migraine	2.85e-05	9.04e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR1A—migraine	2.85e-05	9.04e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EDNRA—migraine	2.84e-05	9.02e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—LRP1—migraine	2.84e-05	9.01e-05	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.82e-05	8.97e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—HTR2A—migraine	2.82e-05	8.96e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NPS—migraine	2.8e-05	8.9e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TAC1—migraine	2.8e-05	8.9e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PGR—migraine	2.8e-05	8.9e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NOTCH3—migraine	2.77e-05	8.79e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR2C—migraine	2.75e-05	8.73e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2B—migraine	2.75e-05	8.73e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFBR2—migraine	2.74e-05	8.71e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFBR2—migraine	2.74e-05	8.71e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HTR7—migraine	2.73e-05	8.68e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CALCA—migraine	2.73e-05	8.68e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—LRP1—migraine	2.73e-05	8.68e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HTR7—migraine	2.69e-05	8.56e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOTCH4—migraine	2.68e-05	8.5e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EDNRA—migraine	2.67e-05	8.49e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—FOS—migraine	2.66e-05	8.45e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFBR2—migraine	2.64e-05	8.4e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOTCH4—migraine	2.61e-05	8.3e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CALCA—migraine	2.61e-05	8.29e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NOTCH3—migraine	2.6e-05	8.27e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFBR2—migraine	2.59e-05	8.21e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR1B—migraine	2.58e-05	8.2e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CALCA—migraine	2.57e-05	8.17e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOTCH4—migraine	2.56e-05	8.12e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR7—migraine	2.56e-05	8.12e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—FOS—migraine	2.54e-05	8.08e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFBR2—migraine	2.52e-05	8.02e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR1B—migraine	2.52e-05	8.01e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOTCH4—migraine	2.52e-05	8e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CALCA—migraine	2.51e-05	7.99e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOTCH4—migraine	2.5e-05	7.96e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—ESR1—migraine	2.5e-05	7.96e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—HTR2A—migraine	2.49e-05	7.92e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR1A—migraine	2.49e-05	7.9e-05	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TNF—migraine	2.47e-05	7.86e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR1B—migraine	2.47e-05	7.84e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—FOS—migraine	2.45e-05	7.78e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TAC1—migraine	2.45e-05	7.78e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NPS—migraine	2.45e-05	7.78e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PGR—migraine	2.45e-05	7.78e-05	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TNF—migraine	2.44e-05	7.75e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HTR2A—migraine	2.44e-05	7.75e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFBR2—migraine	2.43e-05	7.73e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR1B—migraine	2.43e-05	7.72e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR1A—migraine	2.43e-05	7.71e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFBR2—migraine	2.42e-05	7.69e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LRP1—migraine	2.42e-05	7.68e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR1B—migraine	2.42e-05	7.67e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR7—migraine	2.41e-05	7.64e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HTR2A—migraine	2.4e-05	7.63e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR2C—migraine	2.4e-05	7.63e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PGR—migraine	2.39e-05	7.59e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NPS—migraine	2.39e-05	7.59e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TAC1—migraine	2.39e-05	7.59e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR1A—migraine	2.38e-05	7.54e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—FOS—migraine	2.37e-05	7.52e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFBR2—migraine	2.35e-05	7.47e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR2C—migraine	2.34e-05	7.44e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NPS—migraine	2.34e-05	7.43e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TAC1—migraine	2.34e-05	7.43e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PGR—migraine	2.34e-05	7.43e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR1A—migraine	2.34e-05	7.43e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EDNRA—migraine	2.34e-05	7.42e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—FOS—migraine	2.34e-05	7.42e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—HTR2A—migraine	2.33e-05	7.41e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR1A—migraine	2.33e-05	7.39e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFBR2—migraine	2.32e-05	7.37e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HTR2A—migraine	2.32e-05	7.35e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TAC1—migraine	2.3e-05	7.31e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PGR—migraine	2.3e-05	7.31e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NPS—migraine	2.3e-05	7.31e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR2C—migraine	2.29e-05	7.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NPS—migraine	2.29e-05	7.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PGR—migraine	2.29e-05	7.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TAC1—migraine	2.29e-05	7.28e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EDNRA—migraine	2.28e-05	7.24e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOTCH3—migraine	2.28e-05	7.23e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR2C—migraine	2.26e-05	7.17e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CALCA—migraine	2.25e-05	7.14e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR2C—migraine	2.25e-05	7.14e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EDNRA—migraine	2.23e-05	7.09e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HTR2A—migraine	2.23e-05	7.08e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HTR2A—migraine	2.23e-05	7.08e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CALCA—migraine	2.23e-05	7.07e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOTCH3—migraine	2.22e-05	7.06e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—FOS—migraine	2.21e-05	7.03e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFBR2—migraine	2.2e-05	6.99e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EDNRA—migraine	2.2e-05	6.98e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CALCA—migraine	2.19e-05	6.97e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EDNRA—migraine	2.19e-05	6.94e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CACNA1A—migraine	2.18e-05	6.93e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOTCH4—migraine	2.18e-05	6.91e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOTCH3—migraine	2.17e-05	6.91e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—FOS—migraine	2.17e-05	6.89e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—ESR1—migraine	2.16e-05	6.88e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HTR2A—migraine	2.15e-05	6.83e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CALCA—migraine	2.15e-05	6.82e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOTCH3—migraine	2.14e-05	6.8e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—ESR1—migraine	2.13e-05	6.78e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOTCH3—migraine	2.13e-05	6.76e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CALCA—migraine	2.11e-05	6.72e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CALCA—migraine	2.1e-05	6.68e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR7—migraine	2.1e-05	6.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFBR2—migraine	2.1e-05	6.68e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—MTHFR—migraine	2.1e-05	6.67e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR1B—migraine	2.1e-05	6.67e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOTCH4—migraine	2.1e-05	6.66e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—FOS—migraine	2.09e-05	6.62e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFBR2—migraine	2.07e-05	6.58e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—ESR1—migraine	2.06e-05	6.53e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR7—migraine	2.05e-05	6.52e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—MTHFR—migraine	2.05e-05	6.51e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HTR2A—migraine	2.03e-05	6.44e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFBR2—migraine	2.03e-05	6.43e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR1B—migraine	2.02e-05	6.42e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR1A—migraine	2.02e-05	6.42e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR7—migraine	2.01e-05	6.38e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TAC1—migraine	1.99e-05	6.32e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PGR—migraine	1.99e-05	6.32e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NPS—migraine	1.99e-05	6.32e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—ESR1—migraine	1.98e-05	6.29e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—ESR1—migraine	1.98e-05	6.29e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR7—migraine	1.98e-05	6.28e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—MTHFR—migraine	1.98e-05	6.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR7—migraine	1.97e-05	6.25e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—MTHFR—migraine	1.97e-05	6.24e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2C—migraine	1.95e-05	6.2e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR1A—migraine	1.95e-05	6.18e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NPS—migraine	1.92e-05	6.09e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PGR—migraine	1.92e-05	6.09e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TAC1—migraine	1.92e-05	6.09e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HTR2A—migraine	1.91e-05	6.08e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—ESR1—migraine	1.91e-05	6.06e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TNF—migraine	1.9e-05	6.05e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EDNRA—migraine	1.9e-05	6.03e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HTR2A—migraine	1.89e-05	5.99e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2C—migraine	1.88e-05	5.97e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOTCH4—migraine	1.86e-05	5.89e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOTCH3—migraine	1.85e-05	5.88e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EDNRA—migraine	1.83e-05	5.81e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CALCA—migraine	1.83e-05	5.8e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—FOS—migraine	1.82e-05	5.79e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TNF—migraine	1.82e-05	5.78e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TNF—migraine	1.81e-05	5.75e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFBR2—migraine	1.81e-05	5.75e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFBR2—migraine	1.79e-05	5.7e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TNF—migraine	1.79e-05	5.69e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR1B—migraine	1.79e-05	5.69e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR2A—migraine	1.79e-05	5.69e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOTCH3—migraine	1.78e-05	5.66e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TNF—migraine	1.78e-05	5.66e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—FOS—migraine	1.78e-05	5.65e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFBR2—migraine	1.77e-05	5.61e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CALCA—migraine	1.76e-05	5.59e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—FOS—migraine	1.74e-05	5.53e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—FOS—migraine	1.73e-05	5.5e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFBR2—migraine	1.73e-05	5.5e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR1A—migraine	1.72e-05	5.47e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—FOS—migraine	1.71e-05	5.44e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR7—migraine	1.71e-05	5.43e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—MTHFR—migraine	1.71e-05	5.42e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—FOS—migraine	1.71e-05	5.42e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFBR2—migraine	1.7e-05	5.41e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—ESR1—migraine	1.7e-05	5.4e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TAC1—migraine	1.7e-05	5.39e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NPS—migraine	1.7e-05	5.39e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PGR—migraine	1.7e-05	5.39e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFBR2—migraine	1.69e-05	5.38e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR2A—migraine	1.69e-05	5.35e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—ESR1—migraine	1.68e-05	5.32e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.67e-05	5.31e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2C—migraine	1.66e-05	5.29e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR7—migraine	1.65e-05	5.23e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—MTHFR—migraine	1.65e-05	5.22e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EDNRA—migraine	1.62e-05	5.14e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—ESR1—migraine	1.59e-05	5.05e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOTCH3—migraine	1.58e-05	5.01e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CALCA—migraine	1.56e-05	4.95e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—migraine	1.55e-05	4.92e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—ESR1—migraine	1.5e-05	4.75e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—FOS—migraine	1.48e-05	4.7e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR2A—migraine	1.47e-05	4.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFBR2—migraine	1.47e-05	4.67e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR7—migraine	1.46e-05	4.63e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—MTHFR—migraine	1.46e-05	4.63e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR2A—migraine	1.44e-05	4.57e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—FOS—migraine	1.43e-05	4.53e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFBR2—migraine	1.42e-05	4.5e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR2A—migraine	1.41e-05	4.47e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR2A—migraine	1.39e-05	4.4e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR2A—migraine	1.38e-05	4.38e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CACNA1A—migraine	1.34e-05	4.27e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—migraine	1.32e-05	4.19e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ESR1—migraine	1.31e-05	4.15e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ESR1—migraine	1.28e-05	4.05e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—FOS—migraine	1.26e-05	4.01e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFBR2—migraine	1.26e-05	3.99e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ESR1—migraine	1.25e-05	3.97e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ESR1—migraine	1.23e-05	3.91e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ESR1—migraine	1.22e-05	3.88e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2A—migraine	1.2e-05	3.8e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2A—migraine	1.15e-05	3.66e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ESR1—migraine	1.06e-05	3.37e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ESR1—migraine	1.02e-05	3.25e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—migraine	1.02e-05	3.24e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ESR1—migraine	9.06e-06	2.88e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—migraine	7.22e-06	2.29e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—migraine	4.45e-06	1.41e-05	CbGpPWpGaD
